Henry Wheeler | Head, Investor Relations |
Mondher Mahjoubi | Chairman and Chief Executive Officer |
Joyson Karakunnel | Executive Vice President and Chief Medical Officer |
Yannis Morel | Executive Vice President, Product Portfolio Strategy and Business Development |
Frederic Lombard | Senior Vice President and Chief Financial Officer |
Daina Graybosch | SVB Leerink |
Liisa Bayko | Evercore ISI |
Keyur Parekh | Goldman Sachs |
Swayampakula Ramakanth | H.C. Wainwright |
Good afternoon, ladies and gentlemen and welcome to the Innate Pharma’s Full Year 2021 Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I will now hand over to Mr. Henry Wheeler, Head of Investor Relations of Innate Pharma to begin. Sir, please go ahead.